Background Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) carries high mortality. Early ...

Here, Andrew Butler - Business Development Manager for Industrial Gases at Atlas Copco - explores how onsite oxygen ...

Smith, C.A. and Pramanik, S. (2026) A Pilot Study on How Microplastic Polluted Rainfall Infiltrates Commonly Eaten Leafy ...

An error has occurred. Please try again. With a Centralmaine.com subscription, you can gift 5 articles each month. It looks like you do not have any active ...

* Combination therapy showed compelling survival and disease control compared to current standard, regardless of PD-L1 status * High GEA burden in Asia, where BeOne holds ZIIHERA rights, signals ...

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced full results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA ® (zanidatamab), a ...

Goldman Sachs upgraded Standard Chartered Plc (SCBFF) to Buy from Neutral on the potential for management to boost its guidance after its 2025 earnings are released or at its investor day in May. The ...

Roche said its giredestrant drug reduced the risk of disease recurrence or death from breast cancer, suggesting potential for the medication to become standard-of-care when the disease is in the ...

ORLANDO, Fla., Dec. 9, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that ...

Please provide your email address to receive an email when new articles are posted on . First-line sacituzumab govitecan significantly improved PFS for metastatic triple-negative breast cancer subset ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...